While the online tools makes clear consumers can use it without obligation, the therapy section give patients information on AstraZeneca products.
The role of digital health technology in managing chronic disease continues to expand, with companies vying for everything from tracking people’s steps to offering the evidence-based National Diabetes Prevention Program (DPP).
The pharmaceutical maker AstraZeneca, whose treatments include dapagliflozin (Farxiga) for diabetes and rosuvastatin (Crestor) to lower cholesterol, joined the fray in 2014 with Fit2Me, a free diet and lifestyle program aimed at those with type 2 diabetes (T2D). Today, the drugmaker announced that Fit2Me, which already has 1.4 million users, will now feature support for patients with cardiovascular risk and disease.
With the update, the program now addresses the country’s 5 most prevalent health conditions: T2D, high cholesterol, high blood pressure, and triglycerides, and heart attack, according to a statement from AstraZeneca. The online program, which covers food choices, exercise options, therapy selection, and support services, “personalizes each user’s plan to accommodate their food and activity preferences,” the statement said.
While the online program makes clear that consumers can use the material without obligation, part of the therapy section advises patients on how to access “information on type 2 diabetes treatment options from AstraZeneca you can discuss with your doctor.”
The upgrade includes a new feature, Fit My Fridge, which helps users prepare healthy meals with ingredients they already have at home, offering help for busy professionals who cannot plan for every meal. More than 10,000 recipes based on guidelines from the American Diabetes Association and American Heart Association are available. The online program is available in mobile formats, the statement said.
Adding a cardiovascular element will “differentiate” Fit2Me from other online programs, according to the statement, making it “one of the only health management tools that allows people to create a customized diet and exercise plan based on food and exercise preferences, as well as health challenge areas.”
“People living with cardiovascular disease frequently deal with a wide range of risk factors that impact everyday health but, importantly, many of these risk factors are modifiable,” said William E. Boden, MD, Scientific Director, Clinical Trials Network, VA Boston Healthcare System. Having a free program like Fit2Me helps people with diabetes or other chronic conditions create sustainable lifestyle changes, he said.
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care
May 30th 2024In this episode of Managed Care Cast, Nihar Desai, MD, MPH, cardiologist and vice chief of Cardiology at the Yale School of Medicine, discusses therapies for cardiovascular conditions as they relate to patient adherence, polypharmacy, and health access.
Listen
Team-Based CINEMA Program Targets SDOH and Precision Care in Diabetes
December 20th 2024Ian Neeland, MD, discusses the CINEMA program's impact on addressing social determinants of health (SDOH) in Ohio and the importance of precision risk tests to reduce cardiovascular metabolic disease risk.
Read More